30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Radius Health Inc (RDUS)

Track

Stock chart
Ticker: RDUS Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Rubric Capital Management LP
1 purchase — total 16,907,067 USD
Buy 11 Aug 2022
Value US$3,612,337.48 | Price 448.61 | Shares 38,259
Buy 10 Aug 2022
Value US$1,937,211.58 | Price 123.99 | Shares 84,320
Buy 18 May 2022
Value US$2,661,001.86 | Price 5.57 | Shares 477,824
Buy 6 Jan 2022
Value US$1,894,410.00 | Price 6.31 | Shares 300,000
Buy 5 Jan 2022
Value US$1,574,650.00 | Price 6.30 | Shares 250,000
Buy 16 Dec 2021
Value US$1,037,752.37 | Price 7.07 | Shares 146,685
Buy 15 Dec 2021
Value US$1,223,636.88 | Price 6.77 | Shares 180,744
Buy 14 Dec 2021
Value US$640,935.53 | Price 6.81 | Shares 94,103
Buy 13 Dec 2021
Value US$1,326,803.24 | Price 7.08 | Shares 187,391
Buy 10 Dec 2021
Value US$5,511,626.92 | Price 7.18 | Shares 768,171
Buy 9 Dec 2021
Value US$2,007,086.56 | Price 7.58 | Shares 264,644
Buy 8 Dec 2021
Value US$4,497,078.23 | Price 8.02 | Shares 560,691
Buy 29 Sep 2021
Value US$1,294,500.00 | Price 12.95 | Shares 100,000
Planned sale 5 Mar 2021
Value US$7,725.60 | Price 20.88 | Shares 370
Sale 25 Feb 2021
Value US$25,025.46 | Price 18.93 | Shares 1,322
Buy 5 Nov 2020
Value US$1,426,230.00 | Price 14.26 | Shares 100,000
Buy 14 Sep 2020
Value US$2,338,680.00 | Price 11.69 | Shares 200,000
Buy 11 Sep 2020
Value US$2,255,117.99 | Price 11.33 | Shares 199,029
Buy 8 Jul 2020
Value US$330,177.50 | Price 13.21 | Shares 25,000
Buy 30 Apr 2020
Value US$787,555.00 | Price 15.75 | Shares 50,000
Planned sale 26 Feb 2020
Value US$49,362.50 | Price 17.95 | Shares 2,750
Sale 26 Feb 2020
Value US$23,169.44 | Price 17.93 | Shares 1,292
Planned sale 26 Feb 2020
Value US$34,553.75 | Price 17.95 | Shares 1,925
Sale 26 Feb 2020
Value US$22,523.85 | Price 17.93 | Shares 1,256
Planned sale 26 Feb 2020
Value US$32,579.25 | Price 17.95 | Shares 1,815
Sale 26 Feb 2020
Value US$15,942.44 | Price 17.93 | Shares 889
Buy 6 Nov 2019
Value US$2,300,300.00 | Price 23.00 | Shares 100,000
Planned sale 1 Jul 2019
Value US$38,966.40 | Price 24.60 | Shares 1,584
Buy 7 Jun 2019
Value US$54,536.00 | Price 21.81 | Shares 2,500
Buy 10 May 2019
Value US$42,860.00 | Price 21.43 | Shares 2,000
Planned sale 16 Apr 2019
Value US$37,329.60 | Price 22.22 | Shares 1,680
Planned sale 16 Apr 2019
Value US$107,136.00 | Price 22.32 | Shares 4,800
Planned sale 16 Apr 2019
Value US$53,328.00 | Price 22.22 | Shares 2,400
Planned sale 11 Apr 2019
Value US$106,320.00 | Price 22.15 | Shares 4,800
Buy 5 Mar 2019
Value US$246,190.08 | Price 19.23 | Shares 12,800
Buy 20 Dec 2018
Value US$868,782.00 | Price 14.48 | Shares 60,000
Buy 17 Dec 2018
Value US$47,130.00 | Price 15.71 | Shares 3,000
Buy 14 Dec 2018
Value US$938,256.00 | Price 15.64 | Shares 60,000
Buy 20 Aug 2018
Value US$1,178,808.00 | Price 19.65 | Shares 60,000
Buy 15 Aug 2018
Value US$1,441,529.61 | Price 20.78 | Shares 69,363
Buy 14 Aug 2018
Value US$2,086,880.00 | Price 20.87 | Shares 100,000
Buy 8 Aug 2018
Value US$1,363,884.00 | Price 22.73 | Shares 60,000
Buy 27 Jul 2018
Value US$1,240,605.00 | Price 24.81 | Shares 50,000
Buy 25 Jul 2018
Value US$1,363,805.00 | Price 27.28 | Shares 50,000
Buy 11 Jun 2018
Value US$1,367,835.00 | Price 27.36 | Shares 50,000
Buy 23 May 2018
Value US$1,156,320.00 | Price 28.91 | Shares 40,000
Buy 21 May 2018
Value US$1,756,380.00 | Price 29.27 | Shares 60,000
Buy 19 Apr 2018
Value US$1,351,936.00 | Price 33.80 | Shares 40,000
Buy 5 Apr 2018
Value US$1,828,845.00 | Price 36.58 | Shares 50,000
Buy 2 Mar 2018
Value US$2,601,448.00 | Price 32.52 | Shares 80,000
Buy 9 Feb 2018
Value US$2,578,762.50 | Price 34.38 | Shares 75,000
Buy 14 Nov 2017
Value US$1,312,390.00 | Price 26.25 | Shares 50,000
Buy 10 Nov 2017
Value US$49,942.78 | Price 28.09 | Shares 1,778
Buy 7 Nov 2017
Value US$197,450.24 | Price 29.04 | Shares 6,800
Buy 3 Nov 2017
Value US$1,457,575.00 | Price 29.15 | Shares 50,000
Buy 26 Oct 2017
Value US$1,547,550.00 | Price 30.95 | Shares 50,000
Buy 25 Oct 2017
Value US$1,642,415.00 | Price 32.85 | Shares 50,000
Buy 15 Sep 2017
Value US$199,608.47 | Price 32.72 | Shares 6,100
Buy 14 Sep 2017
Value US$98,502.90 | Price 32.83 | Shares 3,000
Buy 14 Sep 2017
Value US$1,647,225.00 | Price 32.94 | Shares 50,000
Buy 13 Sep 2017
Value US$3,370,750.00 | Price 33.71 | Shares 100,000
Buy 12 Sep 2017
Value US$1,770,820.00 | Price 35.42 | Shares 50,000
Buy 5 Sep 2017
Value US$1,837,625.00 | Price 36.75 | Shares 50,000
Buy 16 Aug 2017
Value US$2,158,536.00 | Price 35.98 | Shares 60,000
Buy 10 Aug 2017
Value US$2,569,500.00 | Price 34.26 | Shares 75,000
Buy 9 Aug 2017
Value US$2,675,527.50 | Price 35.67 | Shares 75,000
Buy 30 May 2017
Value US$1,368,348.00 | Price 34.21 | Shares 40,000
Buy 25 May 2017
Value US$1,450,020.00 | Price 36.25 | Shares 40,000
Buy 18 May 2017
Value US$1,720,345.00 | Price 34.41 | Shares 50,000
Buy 17 May 2017
Value US$593,661.60 | Price 32.98 | Shares 18,000
Buy 16 May 2017
Value US$576,725.00 | Price 33.93 | Shares 17,000
Buy 12 May 2017
Value US$509,995.50 | Price 34.00 | Shares 15,000
Buy 9 May 2017
Value US$1,796,480.00 | Price 35.93 | Shares 50,000
Buy 8 May 2017
Value US$811,629.84 | Price 35.60 | Shares 22,800
Buy 5 May 2017
Value US$732,282.62 | Price 35.55 | Shares 20,600
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-08-12 2022-08-11 B Purchase
3.6
Rubric Capital Management LP
Large shareholder
38,259 +33.7%
448.61
US$3,612,337 		38,259 +33.7% 448.61 US$3,612,337
2022-08-11 2022-08-10 B Purchase
3.6
Rubric Capital Management LP
Large shareholder
84,320 -1.0%
123.99
US$1,937,212 		84,320 -1.0% 123.99 US$1,937,212
2022-05-20 2022-05-18 B Purchase
2.4
BIOTECH TARGET N V
Large shareholder
99,230 -37.3%
185.25
US$1,626,849 		99,230 -37.3% 185.25 US$1,626,849
2022-01-07 2022-01-06 B Purchase
2.4
BIOTECH TARGET N V
Large shareholder
300,000 +3.8%
6.31
US$1,894,410 		300,000 +3.8% 6.31 US$1,894,410
2022-01-07 2022-01-05 B Purchase
2.4
BIOTECH TARGET N V
Large shareholder
250,000 +3.2%
6.30
US$1,574,650 		250,000 +3.2% 6.30 US$1,574,650
2021-12-16 2021-12-16 B Purchase
3.6
Rubric Capital Management LP
Large shareholder
146,685 +2.2%
7.07
US$1,037,752 		146,685 +2.2% 7.07 US$1,037,752
2021-12-15 2021-12-15 B Purchase
3.6
Rubric Capital Management LP
Large shareholder
180,744 +2.7%
6.77
US$1,223,637 		180,744 +2.7% 6.77 US$1,223,637
2021-12-15 2021-12-14 B Purchase
3.6
Rubric Capital Management LP
Large shareholder
94,103 +1.4%
6.81
US$640,936 		94,103 +1.4% 6.81 US$640,936
2021-12-15 2021-12-13 B Purchase
3.6
Rubric Capital Management LP
Large shareholder
187,391 +3.0%
7.08
US$1,326,803 		187,391 +3.0% 7.08 US$1,326,803
2021-12-10 2021-12-10 B Purchase
3.6
Rubric Capital Management LP
Large shareholder
768,171 +13.8%
7.18
US$5,511,627 		768,171 +13.8% 7.18 US$5,511,627
2021-12-10 2021-12-09 B Purchase
3.6
Rubric Capital Management LP
Large shareholder
264,644 +5.0%
7.58
US$2,007,087 		264,644 +5.0% 7.58 US$2,007,087
2021-12-10 2021-12-08 B Purchase
3.6
Rubric Capital Management LP
Large shareholder
560,691 +11.8%
8.02
US$4,497,078 		560,691 +11.8% 8.02 US$4,497,078
2021-10-01 2021-09-29 B Purchase
2.4
BIOTECH TARGET N V
Large shareholder
100,000 +1.3%
12.95
US$1,294,500 		100,000 +1.3% 12.95 US$1,294,500
2021-03-09 2021-03-05 PlS Planned sale
3.6
Chopas James George

Principal Finance Accounting

Officer
370 -5.2%
20.88
US$7,726 		370 -5.2% 20.88 US$7,726
2021-02-26 2021-02-25 S Sale
Grausso Sal

Chief Commercial Officer

Officer
1,322 -10.1%
18.93
US$25,025 		1,322 -10.1% 18.93 US$25,025
2020-11-09 2020-11-05 B Purchase
2.4
BIOTECH TARGET N V
Large shareholder
100,000 +1.4%
14.26
US$1,426,230 		100,000 +1.4% 14.26 US$1,426,230
2020-09-16 2020-09-14 B Purchase
2.4
BIOTECH TARGET N V
Large shareholder
200,000 +2.8%
11.69
US$2,338,680 		200,000 +2.8% 11.69 US$2,338,680
2020-09-14 2020-09-11 B Purchase
2.4
BIOTECH TARGET N V
Large shareholder
199,029 +2.9%
11.33
US$2,255,118 		199,029 +2.9% 11.33 US$2,255,118
2020-07-09 2020-07-08 B Purchase
2.4
BIOTECH TARGET N V
Large shareholder
25,000 +0.4%
13.21
US$330,178 		25,000 +0.4% 13.21 US$330,178
2020-05-04 2020-04-30 B Purchase
2.4
BIOTECH TARGET N V
Large shareholder
50,000 +0.7%
15.75
US$787,555 		50,000 +0.7% 15.75 US$787,555
2020-02-28 2020-02-26 PlS Planned sale
3.0
Hughes Owen
Non-Executive Director
2,750 -20.5%
17.95
US$49,362 		2,750 -20.5% 17.95 US$49,362
2020-02-28 2020-02-26 S Sale
Carmona Jose

Chief Financial Officer

Officer
1,292 -2.7%
17.93
US$23,169 		1,292 -2.7% 17.93 US$23,169
2020-02-28 2020-02-26 PlS Planned sale
Dere Willard H
Non-Executive Director
1,925 -13.6%
17.95
US$34,554 		1,925 -13.6% 17.95 US$34,554
2020-02-28 2020-02-26 S Sale
Morris Charles Q

Chief Medical Officer

Officer
1,256 -3.6%
17.93
US$22,524 		1,256 -3.6% 17.93 US$22,524
2020-02-28 2020-02-26 PlS Planned sale
Rosenberg Anthony
Non-Executive Director
1,815 -12.8%
17.95
US$32,579 		1,815 -12.8% 17.95 US$32,579
2020-02-28 2020-02-26 S Sale
3.0
Kelly Joseph Francis

Sr. VP of Sales and Marketing

Officer
889 -3.6%
17.93
US$15,942 		889 -3.6% 17.93 US$15,942
2019-11-08 2019-11-06 B Purchase BIOTECH GROWTH N V Large shareholder
100,000 +1.5%
23.00
US$2,300,300 		100,000 +1.5% 23.00 US$2,300,300
2019-07-03 2019-07-01 PlS Planned sale
Rosenberg Anthony
1,584 -15.4%
24.60
US$38,966 		1,584 -15.4% 24.60 US$38,966
2019-06-11 2019-06-07 B Purchase
3.0
Kelly Joseph Francis

Sr. VP of Sales and Marketing
2,500 +50.0%
21.81
US$54,536 		2,500 +50.0% 21.81 US$54,536
2019-05-13 2019-05-10 B Purchase
3.0
Kelly Joseph Francis

Sr. VP of Sales and Marketing
2,000 +66.7%
21.43
US$42,860 		2,000 +66.7% 21.43 US$42,860
2019-04-18 2019-04-16 PlS Planned sale
Dere Willard H
1,680 -16.3%
22.22
US$37,330 		1,680 -16.3% 22.22 US$37,330
2019-04-18 2019-04-16 PlS Planned sale
Graves Kurt
4,800 -46.6%
22.32
US$107,136 		4,800 -46.6% 22.32 US$107,136
2019-04-18 2019-04-16 PlS Planned sale
3.0
Hughes Owen
2,400 -23.3%
22.22
US$53,328 		2,400 -23.3% 22.22 US$53,328
2019-04-12 2019-04-11 PlS Planned sale
Roychowdhury Debasish
4,800 -46.6%
22.15
US$106,320 		4,800 -46.6% 22.15 US$106,320
2019-03-06 2019-03-05 B Purchase
3.2
Hopfield Jessica
12,800 +inf%
19.23
US$246,190 		12,800 +inf% 19.23 US$246,190
2018-12-21 2018-12-20 B Purchase BIOTECH GROWTH N V Large shareholder
60,000 +0.9%
14.48
US$868,782 		60,000 +0.9% 14.48 US$868,782
2018-12-18 2018-12-17 B Purchase Kelly Joseph Francis

Sr. VP of Sales and Marketing

Officer
3,000 +inf%
15.71
US$47,130 		3,000 +inf% 15.71 US$47,130
2018-12-17 2018-12-14 B Purchase BIOTECH GROWTH N V Large shareholder
60,000 +0.9%
15.64
US$938,256 		60,000 +0.9% 15.64 US$938,256
2018-08-22 2018-08-20 B Purchase BIOTECH GROWTH N V Large shareholder
60,000 +0.9%
19.65
US$1,178,808 		60,000 +0.9% 19.65 US$1,178,808
2018-08-16 2018-08-15 B Purchase BIOTECH GROWTH N V Large shareholder
69,363 +1.1%
20.78
US$1,441,530 		69,363 +1.1% 20.78 US$1,441,530
2018-08-16 2018-08-14 B Purchase BIOTECH GROWTH N V Large shareholder
100,000 +1.6%
20.87
US$2,086,880 		100,000 +1.6% 20.87 US$2,086,880
2018-08-10 2018-08-08 B Purchase BIOTECH GROWTH N V Large shareholder
60,000 +1.0%
22.73
US$1,363,884 		60,000 +1.0% 22.73 US$1,363,884
2018-07-30 2018-07-27 B Purchase BIOTECH GROWTH N V Large shareholder
50,000 +0.8%
24.81
US$1,240,605 		50,000 +0.8% 24.81 US$1,240,605
2018-07-26 2018-07-25 B Purchase BIOTECH GROWTH N V Large shareholder
50,000 +0.8%
27.28
US$1,363,805 		50,000 +0.8% 27.28 US$1,363,805
2018-06-13 2018-06-11 B Purchase BIOTECH GROWTH N V Large shareholder
50,000 +0.8%
27.36
US$1,367,835 		50,000 +0.8% 27.36 US$1,367,835
2018-05-24 2018-05-23 B Purchase BIOTECH GROWTH N V Large shareholder
40,000 +0.7%
28.91
US$1,156,320 		40,000 +0.7% 28.91 US$1,156,320
2018-05-23 2018-05-21 B Purchase BIOTECH GROWTH N V Large shareholder
60,000 +1.0%
29.27
US$1,756,380 		60,000 +1.0% 29.27 US$1,756,380
2018-04-23 2018-04-19 B Purchase BIOTECH GROWTH N V Large shareholder
40,000 +0.7%
33.80
US$1,351,936 		40,000 +0.7% 33.80 US$1,351,936
2018-04-09 2018-04-05 B Purchase BIOTECH GROWTH N V Large shareholder
50,000 +0.9%
36.58
US$1,828,845 		50,000 +0.9% 36.58 US$1,828,845
2018-03-06 2018-03-02 B Purchase BIOTECH GROWTH N V Large shareholder
80,000 +1.4%
32.52
US$2,601,448 		80,000 +1.4% 32.52 US$2,601,448
2018-02-12 2018-02-09 B Purchase BIOTECH GROWTH N V Large shareholder
75,000 +1.3%
34.38
US$2,578,762 		75,000 +1.3% 34.38 US$2,578,762
2017-11-16 2017-11-14 B Purchase BIOTECH GROWTH N V Large shareholder
50,000 +0.9%
26.25
US$1,312,390 		50,000 +0.9% 26.25 US$1,312,390
2017-11-13 2017-11-10 B Purchase Hatzis-Schoch Brent

Sr. VP, General Counsel
1,778 +355.6%
28.09
US$49,943 		1,778 +355.6% 28.09 US$49,943
2017-11-07 2017-11-07 B Purchase Hoiland Jesper

President and CEO

Executive Director
6,800 +111.5%
29.04
US$197,450 		6,800 +111.5% 29.04 US$197,450
2017-11-07 2017-11-03 B Purchase BIOTECH GROWTH N V Large shareholder
50,000 +0.9%
29.15
US$1,457,575 		50,000 +0.9% 29.15 US$1,457,575
2017-10-27 2017-10-26 B Purchase BIOTECH GROWTH N V Large shareholder
50,000 +0.9%
30.95
US$1,547,550 		50,000 +0.9% 30.95 US$1,547,550
2017-10-26 2017-10-25 B Purchase BIOTECH GROWTH N V Large shareholder
50,000 +0.9%
32.85
US$1,642,415 		50,000 +0.9% 32.85 US$1,642,415
2017-09-15 2017-09-15 B Purchase Hoiland Jesper

President and CEO

Executive Director
6,100 +inf%
32.72
US$199,608 		6,100 +inf% 32.72 US$199,608
2017-09-15 2017-09-14 B Purchase Carmona Jose

Chief Financial Officer
3,000 +inf%
32.83
US$98,503 		3,000 +inf% 32.83 US$98,503
2017-09-15 2017-09-14 B Purchase BIOTECH GROWTH N V Large shareholder
50,000 +0.9%
32.94
US$1,647,225 		50,000 +0.9% 32.94 US$1,647,225
2017-09-15 2017-09-13 B Purchase BIOTECH GROWTH N V Large shareholder
100,000 +1.9%
33.71
US$3,370,750 		100,000 +1.9% 33.71 US$3,370,750
2017-09-13 2017-09-12 B Purchase BIOTECH GROWTH N V Large shareholder
50,000 +0.9%
35.42
US$1,770,820 		50,000 +0.9% 35.42 US$1,770,820
2017-09-07 2017-09-05 B Purchase BIOTECH GROWTH N V Large shareholder
50,000 +1.0%
36.75
US$1,837,625 		50,000 +1.0% 36.75 US$1,837,625
2017-08-18 2017-08-16 B Purchase BIOTECH GROWTH N V Large shareholder
60,000 +1.2%
35.98
US$2,158,536 		60,000 +1.2% 35.98 US$2,158,536
2017-08-11 2017-08-10 B Purchase BIOTECH GROWTH N V Large shareholder
75,000 +1.5%
34.26
US$2,569,500 		75,000 +1.5% 34.26 US$2,569,500
2017-08-11 2017-08-09 B Purchase BIOTECH GROWTH N V Large shareholder
75,000 +1.5%
35.67
US$2,675,528 		75,000 +1.5% 35.67 US$2,675,528
2017-05-31 2017-05-30 B Purchase BIOTECH GROWTH N V Large shareholder
40,000 +0.8%
34.21
US$1,368,348 		40,000 +0.8% 34.21 US$1,368,348
2017-05-30 2017-05-25 B Purchase BIOTECH GROWTH N V Large shareholder
40,000 +0.8%
36.25
US$1,450,020 		40,000 +0.8% 36.25 US$1,450,020
2017-05-22 2017-05-18 B Purchase BIOTECH GROWTH N V Large shareholder
50,000 +1.0%
34.41
US$1,720,345 		50,000 +1.0% 34.41 US$1,720,345
2017-05-18 2017-05-17 B Purchase BIOTECH GROWTH N V Large shareholder
18,000 +0.4%
32.98
US$593,662 		18,000 +0.4% 32.98 US$593,662
2017-05-18 2017-05-16 B Purchase BIOTECH GROWTH N V Large shareholder
17,000 +0.3%
33.93
US$576,725 		17,000 +0.3% 33.93 US$576,725
2017-05-16 2017-05-12 B Purchase BIOTECH GROWTH N V Large shareholder
15,000 +0.3%
34.00
US$509,996 		15,000 +0.3% 34.00 US$509,996
2017-05-11 2017-05-09 B Purchase BIOTECH GROWTH N V Large shareholder
50,000 +1.0%
35.93
US$1,796,480 		50,000 +1.0% 35.93 US$1,796,480
2017-05-09 2017-05-08 B Purchase BIOTECH GROWTH N V Large shareholder
22,800 +0.5%
35.60
US$811,630 		22,800 +0.5% 35.60 US$811,630
2017-05-09 2017-05-05 B Purchase BIOTECH GROWTH N V Large shareholder
20,600 +0.4%
35.55
US$732,283 		20,600 +0.4% 35.55 US$732,283
Explore more

More insider trading research around Radius Health Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America